Nathaniel Smith

601 total citations
25 papers, 315 citations indexed

About

Nathaniel Smith is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Nathaniel Smith has authored 25 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Hepatology and 9 papers in Oncology. Recurrent topics in Nathaniel Smith's work include Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (7 papers) and CAR-T cell therapy research (6 papers). Nathaniel Smith is often cited by papers focused on Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (7 papers) and CAR-T cell therapy research (6 papers). Nathaniel Smith collaborates with scholars based in United States, United Kingdom and Australia. Nathaniel Smith's co-authors include Rachel Beckerman, Zobair M. Younossi, Maria Stepanova, Yushan Jiang, Fadoua El Moustaid, Loice Achieng, Stefan Mauss, Marı́a Buti, Ashley Brown and Lawrence Serfaty and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

Nathaniel Smith

23 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathaniel Smith United States 11 139 128 72 70 38 25 315
Ross Murtagh Ireland 9 116 0.8× 74 0.6× 108 1.5× 68 1.0× 78 2.1× 16 306
Aisha Khan United States 7 206 1.5× 210 1.6× 23 0.3× 46 0.7× 22 0.6× 11 301
Anna Esteve Spain 13 211 1.5× 19 0.1× 235 3.3× 135 1.9× 96 2.5× 37 392
Patrizia Künzler‐Heule Switzerland 9 294 2.1× 272 2.1× 58 0.8× 9 0.1× 11 0.3× 21 425
Zameer Mohamed United Kingdom 12 229 1.6× 236 1.8× 74 1.0× 23 0.3× 7 0.2× 24 366
Susan Parker United States 8 101 0.7× 72 0.6× 14 0.2× 22 0.3× 16 0.4× 20 229
Sara de la Fuente Spain 7 101 0.7× 55 0.4× 109 1.5× 29 0.4× 19 0.5× 25 222
Helen Li United States 10 149 1.1× 57 0.4× 20 0.3× 15 0.2× 102 2.7× 20 377
Elena Álvarez Spain 7 66 0.5× 47 0.4× 144 2.0× 7 0.1× 76 2.0× 12 239
Herminia Esteban Spain 9 115 0.8× 78 0.6× 236 3.3× 72 1.0× 148 3.9× 13 366

Countries citing papers authored by Nathaniel Smith

Since Specialization
Citations

This map shows the geographic impact of Nathaniel Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel Smith more than expected).

Fields of papers citing papers by Nathaniel Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathaniel Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel Smith. The network helps show where Nathaniel Smith may publish in the future.

Co-authorship network of co-authors of Nathaniel Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Nathaniel Smith. A scholar is included among the top collaborators of Nathaniel Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathaniel Smith. Nathaniel Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perales, Miguel‐Angel, Olalekan O. Oluwole, Anik R. Patel, et al.. (2025). Validation of Cure Assumptions when Analyzing ZUMA-7 Follow-up Data of Axicabtagene Ciloleucel and Standard of Care Therapy in Second-Line Relapsed/Refractory Large B-cell Lymphoma. Transplantation and Cellular Therapy. 31(12). 1004.e1–1004.e12.
2.
Kaushik, Ankita, Geoffrey Dusheiko, Chong Kim, et al.. (2024). Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness Studies. PharmacoEconomics - Open. 8(2). 333–343. 2 indexed citations
3.
Sinakos, Emmanouil, et al.. (2024). Cost–effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece. Journal of Comparative Effectiveness Research. 13(4). e230090–e230090.
4.
Kisiel, John B., Lianne Barnieh, Nathaniel Smith, et al.. (2023). The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population. Journal of Medical Economics. 26(1). 1219–1226. 4 indexed citations
5.
Gish, Robert G., Robert J. Wong, Gian Luca Di Tanna, et al.. (2023). Association of hepatitis delta virus with liver morbidity and mortality: A systematic literature review and meta-analysis. Hepatology. 79(5). 1129–1140. 22 indexed citations
6.
Oluwole, Olalekan O., Anik R. Patel, Nathaniel Smith, et al.. (2023). An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States. Journal of Medical Economics. 27(1). 77–83. 8 indexed citations
7.
8.
Kriss, Jennifer L., Peter Boersma, Jennifer Adjemian, et al.. (2022). Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox — United States, May 22–October 10, 2022. MMWR Morbidity and Mortality Weekly Report. 71(43). 1374–1378. 31 indexed citations
9.
Beckerman, Rachel, Andrea Gori, Jakob J Malin, et al.. (2022). Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis. Scientific Reports. 12(1). 9622–9622. 20 indexed citations
10.
Shah, Bijal, Nathaniel Smith, Chaoling Feng, et al.. (2022). Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States. Advances in Therapy. 39(8). 3678–3695. 6 indexed citations
11.
12.
Perales, Miguel‐Angel, John Kuruvilla, Julia Thornton Snider, et al.. (2022). Cost-Effectiveness of Axicabtagene Ciloleucel As Second-Line Therapy for Patients Large B-Cell Lymphoma (LBCL) in the United States. Transplantation and Cellular Therapy. 28(3). S475–S475. 2 indexed citations
13.
Perales, Miguel‐Angel, John Kuruvilla, Julia Thornton Snider, et al.. (2022). The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Therapy in Patients with Large B-Cell Lymphoma in the United States: An Economic Evaluation of the ZUMA-7 Trial. Transplantation and Cellular Therapy. 28(11). 750.e1–750.e6. 25 indexed citations
14.
Kaplan, David E., et al.. (2022). Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective. Journal of Managed Care & Specialty Pharmacy. 28(10). 1138–1148. 8 indexed citations
15.
Karlitz, Jordan J., A. Mark Fendrick, Jay Bhatt, et al.. (2021). Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population. Population Health Management. 25(3). 343–351. 10 indexed citations
16.
Fisher, Deborah A., Jordan J. Karlitz, Nathaniel Smith, et al.. (2021). Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population. Journal of Medical Economics. 24(1). 654–664. 14 indexed citations
17.
Younossi, Zobair M., Nathaniel Smith, Maria Stepanova, et al.. (2015). 228 The Impact of Sustained Viral Eradication on the Work Productivity of Patients With Chronic Hepatitis C (CHC) From the Five Western European Countries and the United States. Gastroenterology. 148(4). S–971. 1 indexed citations
18.
Achieng, Loice, et al.. (2013). The Use of Pill Counts as a Facilitator of Adherence with Antiretroviral Therapy in Resource Limited Settings. PLoS ONE. 8(12). e67259–e67259. 19 indexed citations
19.
20.
Smith, Nathaniel, et al.. (2012). A Model for Reduced HIV-1 Viral Load Monitoring in Resource-Limited Settings. Journal of the International Association of Providers of AIDS Care (JIAPAC). 12(1). 67–71. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ross Murtagh Breakdown of academic impact, for papers by Aisha Khan Breakdown of academic impact, for papers by Anna Esteve Breakdown of academic impact, for papers by Patrizia Künzler‐Heule Breakdown of academic impact, for papers by Zameer Mohamed Breakdown of academic impact, for papers by Susan Parker Breakdown of academic impact, for papers by Sara de la Fuente Breakdown of academic impact, for papers by Helen Li Breakdown of academic impact, for papers by Elena Álvarez Breakdown of academic impact, for papers by Herminia Esteban
Rankless by CCL
2026